
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BLUE] bluebird bio Inc - EBITDA / Share
Data updated 2023-Sep-24 (Sunday)Note: Detailed Statistics for EBITDA / Share in Income Statement for bluebird bio Inc [NASDAQ:BLUE] with frequency distribution chart that analyze trends & history . EBITDA per share is a valuation metric calculated as EBITDA / Shares Outstanding. View Income Statement for broader context
Share
Quarterly EBITDA / Share values for bluebird bio Inc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
EBITDA / Share | -0.78 | -0.81 | -0.88 | -1.04 | -1.35 | -1.62 |
Sequential Quarter Growth | +3.7% | +8.0% | +15.4% | +23.0% | +16.7% | +11.5% |
Quarter-on Quarter Growth | +42.2% | +50.0% | +51.9% | +62.6% | +61.2% | +51.9% |
Annual EBITDA / Share values for bluebird bio Inc are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | 2017-Dec | |
---|---|---|---|---|---|---|
EBITDA / Share | -4.82 | -8.06 | -8.9 | -14.4 | -10.6 | -7.33 |
Year-on-Year Growth | +40.2% | +9.4% | +38.2% | -35.7% | -44.7% | -7.5% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly EBITDA / Share values from 2015-Sep-30 grouped into buckets. Latest EBITDA / Share value is -0.78 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for bluebird bio Inc mapped with quarterly EBITDA / Share values reported at that time. Most recent value denoted with star
Select frequency and calculation type for EBITDA / Share above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for bluebird bio Inc with subsequent post-earnings performance given EBITDA / Share values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
EBITDA / Share - Low | 56% | 44% |
EBITDA / Share - Medium | 42% | 58% |
EBITDA / Share - High | 62% | 38% |
EBITDA / Share (Sequential growth %) - Low | 52% | 48% |
EBITDA / Share (Sequential growth %) - Medium | 21% | 79% |
EBITDA / Share (Sequential growth %) - High | 81% | 19% |
EBITDA / Share (QoQ growth %) - Low | 57% | 43% |
EBITDA / Share (QoQ growth %) - Medium | 46% | 54% |
EBITDA / Share (QoQ growth %) - High | 46% | 54% |
Related to bluebird bio Inc
Information for bluebird bio Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-30 on Google
SEC Reports : Quarterly reports around 2025-May-30 on SEC Edgar
Compare bluebird bio Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes bluebird bio Inc
Industry : Biotechnology industry performance which includes bluebird bio Inc